Payment overview · 2025
General Payments
$58.63
2 reported records · 2 companies
Healthcare provider profile · identity verified
Parvez Karim, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · GREENVILLE, MS · NPI 1275562464
Verified facts
What the public records show
CMS Open Payments records show Parvez Karim, M.D. received $58.63 in general payments during 2025 across 2 reported records.
Alpha Cognition USA, Inc. accounted for 54.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 124 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LUMIGAN as an associated drug or biological on 25016 records involving 7645 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Lumigan by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Alpha Cognition USA, Inc. | Unresolved — no canonical attribution shown | $31.67 | 54.0% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $26.96 | 46.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $58.63 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Zunveyl Normalized: zunveyl |
Drug | Alpha Cognition USA, Inc. | $31.67 | 1 | 2025 |
Source payment records
|
|||||
| DALVANCE Normalized: dalvance |
Drug | ABBVIE INC. | $26.96 | 1 | 2025 |
Source payment records
|
|||||
| EMBLAVEO Normalized: emblaveo |
Drug | ABBVIE INC. | $26.96 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
124 | 29 |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LUMIGAN open payments reported associated product |
CMS Open Payments — General Payments 25016 supporting records · 7645 recipient NPIs · example record 1201352548 |
Lumigan · 2024 Exact normalized brand match · 1 Part D row |
27 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 1117 | 163 |
| Atorvastatin Calcium | Atorvastatin Calcium | 953 | 94 |
| Losartan Potassium | Losartan Potassium | 762 | 70 |
| Donepezil Hcl | Donepezil Hcl | 681 | 51 |
| Furosemide | Furosemide | 625 | 95 |
| Potassium Chloride | Potassium Chloride | 622 | 102 |
| Pantoprazole Sodium | Pantoprazole Sodium | 617 | 77 |
| Eliquis | Apixaban | 599 | 45 |
| Carvedilol | Carvedilol | 545 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 530 | 62 |
| Gabapentin | Gabapentin | 508 | 70 |
| Famotidine | Famotidine | 433 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 405 | 53 |
| Levetiracetam | Levetiracetam | 394 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 394 | 33 |
| Hydralazine Hcl | Hydralazine Hcl | 364 | 52 |
| Quetiapine Fumarate | Quetiapine Fumarate | 362 | 27 |
| Hydrochlorothiazide | Hydrochlorothiazide | 360 | 53 |
| Citalopram Hbr | Citalopram Hydrobromide | 348 | 20 |
| Memantine Hcl | Memantine Hcl | 339 | 16 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 332 | 62 |
| Metformin Hcl | Metformin Hcl | 325 | 42 |
| Metoprolol Tartrate | Metoprolol Tartrate | 313 | 44 |
| Meloxicam | Meloxicam | 304 | 54 |
| Levothyroxine Sodium | Levothyroxine Sodium | 289 | 42 |
| Trazodone Hcl | Trazodone Hcl | 280 | 18 |
| Divalproex Sodium | Divalproex Sodium | 266 | 11 |
| Lisinopril | Lisinopril | 259 | 30 |
| Entresto | Sacubitril/Valsartan | 244 | 12 |
| Spironolactone | Spironolactone | 243 | 26 |
| Januvia | Sitagliptin Phosphate | 233 | 25 |
| Xarelto | Rivaroxaban | 219 | 23 |
| Simvastatin | Simvastatin | 208 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 199 | 18 |
| Omeprazole | Omeprazole | 197 | 37 |
| Pravastatin Sodium | Pravastatin Sodium | 197 | 28 |
| Allopurinol | Allopurinol | 173 | 25 |
| Farxiga | Dapagliflozin Propanediol | 148 | 12 |
| Prednisone | Prednisone | 144 | 16 |
| Sevelamer Carbonate | Sevelamer Carbonate | 139 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 138 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 135 | 13 |
| Haloperidol | Haloperidol | 128 | 11 |
| Amiodarone Hcl | Amiodarone Hcl | 127 | 16 |
| Risperidone | Risperidone | 126 | suppressed |
| Mirtazapine | Mirtazapine | 125 | 16 |
| Linzess | Linaclotide | 124 | 29 |
| Olanzapine | Olanzapine | 124 | suppressed |
| Glimepiride | Glimepiride | 121 | 24 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 114 | 13 |
| Jardiance | Empagliflozin | 110 | suppressed |
| Ozempic | Semaglutide | 110 | 20 |
| Glipizide | Glipizide | 106 | 14 |
| Brilinta | Ticagrelor | 105 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 104 | 20 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 96 | suppressed |
| Torsemide | Torsemide | 88 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 87 | 11 |
| Irbesartan | Irbesartan | 84 | suppressed |
| Nifedipine Er | Nifedipine | 82 | 14 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 81 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 81 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 81 | suppressed |
| Topiramate | Topiramate | 81 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 79 | 33 |
| Bumetanide | Bumetanide | 77 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 75 | 21 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 74 | suppressed |
| Baclofen | Baclofen | 70 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 68 | suppressed |
| Lovastatin | Lovastatin | 68 | 16 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 67 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 67 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 66 | suppressed |
| Ranolazine Er | Ranolazine | 65 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 63 | 29 |
| Azithromycin | Azithromycin | 62 | 49 |
| Buspirone Hcl | Buspirone Hcl | 62 | suppressed |
| Colchicine | Colchicine | 62 | 18 |
| Hydroxyurea | Hydroxyurea | 61 | suppressed |
| Novolog Flexpen | Insulin Aspart | 60 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 57 | 18 |
| Metolazone | Metolazone | 56 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 56 | suppressed |
| Cilostazol | Cilostazol | 54 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 54 | 54 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 53 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 53 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 52 | suppressed |
| Novolin R | Insulin Regular, Human | 52 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 51 | 19 |
| Ibuprofen | Ibuprofen | 50 | 25 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 49 | 41 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 49 | 20 |
| Latanoprost | Latanoprost | 49 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 47 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 45 | 12 |
| Carbamazepine | Carbamazepine | 44 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 44 | 13 |
| Metoclopramide Hcl | Metoclopramide Hcl | 41 | suppressed |
| Sucralfate | Sucralfate | 40 | suppressed |
| Pregabalin | Pregabalin | 39 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 38 | 36 |
| Novolin N | Insulin Nph Human Isophane | 38 | suppressed |
| Clonazepam | Clonazepam | 37 | 14 |
| Glipizide Er | Glipizide | 37 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | 14 |
| Lamotrigine | Lamotrigine | 36 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 36 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 35 | suppressed |
| Insulin Lispro | Insulin Lispro | 35 | suppressed |
| Levofloxacin | Levofloxacin | 35 | 34 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | suppressed |
| Aripiprazole | Aripiprazole | 34 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 34 | 11 |
| Novolog | Insulin Aspart | 34 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 32 | 31 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | 15 |
| Lactulose | Lactulose | 31 | suppressed |
| Ezetimibe | Ezetimibe | 30 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 30 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 29 | 14 |
| Meclizine Hcl | Meclizine Hcl | 29 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Lumigan | Bimatoprost | 27 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 27 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 27 | 13 |
| Atenolol | Atenolol | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 26 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 25 | suppressed |
| Nystatin | Nystatin | 25 | 11 |
| Alendronate Sodium | Alendronate Sodium | 24 | suppressed |
| Amoxicillin | Amoxicillin | 24 | 15 |
| Cephalexin | Cephalexin | 23 | 22 |
| Divalproex Sodium Er | Divalproex Sodium | 23 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 23 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Levemir Flexpen | Insulin Detemir | 23 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 22 | suppressed |
| Digoxin | Digoxin | 22 | suppressed |
| Scopolamine | Scopolamine | 22 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Mitigare | Colchicine | 21 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 20 | suppressed |
| Clonidine | Clonidine | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Levemir | Insulin Detemir | 20 | 11 |
| Nortriptyline Hcl | Nortriptyline Hcl | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Acyclovir | Acyclovir | 18 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 18 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 17 | 15 |
| Bupropion Xl | Bupropion Hcl | 17 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 17 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Fluconazole | Fluconazole | 17 | 14 |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 16 |
| Acetazolamide | Acetazolamide | 16 | suppressed |
| Alprazolam | Alprazolam | 16 | suppressed |
| Bicalutamide | Bicalutamide | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 16 | suppressed |
| Nadolol | Nadolol | 16 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | 11 |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 15 | 13 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 14 | suppressed |
| Felodipine Er | Felodipine | 14 | suppressed |
| Fluphenazine Decanoate | Fluphenazine Decanoate | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Propafenone Hcl | Propafenone Hcl | 14 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 14 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 14 | suppressed |
| Xifaxan | Rifaximin | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 13 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 13 | 13 |
| Metronidazole | Metronidazole | 13 | 13 |
| Movantik | Naloxegol Oxalate | 13 | suppressed |
| Phenytoin | Phenytoin | 13 | suppressed |
| Welchol | Colesevelam Hcl | 13 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 12 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Lacosamide | Lacosamide | 11 | suppressed |
| Odefsey | Emtricitab/Rilpiviri/Tenof Ala | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $58.63 · 2 records | Alpha Cognition USA, Inc. | DALVANCE, EMBLAVEO, Zunveyl | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error